======= ING5 ======= == Gene Information == * **Official Symbol**: ING5 * **Official Name**: inhibitor of growth family member 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84289|84289]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WYH8|Q8WYH8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ING5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ING5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608525|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the HBO1 complex which has a histone H4- specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. Through chromatin acetylation it may regulate DNA replication and may function as a transcriptional coactivator. {ECO:0000269|PubMed:12750254, ECO:0000269|PubMed:16387653}. |ING| |PHD| |MOZ/MORF histone acetyltransferase complex| |histone H3 acetylation| |methylated histone binding| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |positive regulation of apoptotic signaling pathway| |regulation of signal transduction by p53 class mediator| |protein acylation| |DNA replication| |negative regulation of growth| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin binding| |regulation of apoptotic signaling pathway| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of growth| |negative regulation of cell population proliferation| |positive regulation of cell death| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |regulation of cell death| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-2.7| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-2.2| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.08| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.94| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.86| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.84| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.75| |[[:results:exp59|UMK57 1μM R01 exp59]]|1.76| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.77| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.77| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.79| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|1.8| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|1.83| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.88| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|1.93| |[[:results:exp34|Rotenone 20μM R00 exp34]]|1.97| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.16| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|2.19| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|2.23| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.48| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.56| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.88| ^Gene^Correlation^ |[[:human genes:m:med13l|MED13L]]|0.51| |[[:human genes:m:med13|MED13]]|0.509| |[[:human genes:z:znf644|ZNF644]]|0.501| |[[:human genes:e:ehmt2|EHMT2]]|0.463| |[[:human genes:m:meaf6|MEAF6]]|0.448| |[[:human genes:z:zc3h18|ZC3H18]]|0.443| |[[:human genes:b:brpf1|BRPF1]]|0.434| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1589 * **Expression level (log2 read counts)**: 6.05 {{:chemogenomics:nalm6 dist.png?nolink |}}